Preliminary Investigation of Mitoxantrone Coating on Stent-Grafts to Inhibit Neointimal Proliferation

Purpose: To investigate the inhibition of neointimal proliferation induced by a stent-graft loaded with mitoxantrone. Methods: Stent-grafts with and without mitoxantrone loading (150 μg per device) were inserted into the carotid artery of 7 and 6 rabbits, respectively. After an observation period of 28 days, the animals were sacrificed, and a detailed morphological and morphometric workup of the stented vessels was performed. Results: Uncoated stent-grafts induced a thick neointima (median diameter 97±99 μm), whereas no neointima formed in mitoxantrone-loaded stent-grafts. However, the loaded devices were not fully covered by an endothelial layer. The underlying media was significantly thinner (31.8±5.6 versus 48.6±3.3 μm, p=0.002) and showed a widespread loss of smooth muscle cells. Conclusions: Mitoxantrone loading of a stent-graft inhibited the formation of a neointima. However, important regenerative processes were prevented as well, indicating a local overdose. More experiments using lower doses are warranted.

[1]  H. Kornhuber,et al.  Treatment of multiple sclerosis with mitoxantrone , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[2]  S. Silber,et al.  High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. , 2004, Journal of the American College of Cardiology.

[3]  R. Erbel,et al.  Media remodeling--the result of stent induced media necrosis and repair. , 2004, VASA. Zeitschrift fur Gefasskrankheiten.

[4]  D. Figgitt,et al.  Mitoxantrone , 2004, CNS drugs.

[5]  S. Silber Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients. , 2003, Journal of interventional cardiology.

[6]  P. Serruys,et al.  Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries , 2003, Circulation.

[7]  A. Widmark New principles in the treatment of prostate cancer--the oncologist's view. , 2003, Scandinavian journal of urology and nephrology. Supplementum.

[8]  P. Fitzgerald,et al.  7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal Growth: An Intravascular Ultrasound Analysis From the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE) , 2002, Circulation.

[9]  H. Bergmeister,et al.  Biocompatibility and performance of the Wallstent and several covered stents in a sheep iliac artery model. , 2001, Journal of vascular and interventional radiology : JVIR.

[10]  G. Rosen,et al.  Recurrent gastrointestinal stromal sarcomas. , 2000, Surgical oncology.

[11]  S. Stepkowski,et al.  Molecular targets for existing and novel immunosuppressive drugs , 2000, Expert Reviews in Molecular Medicine.

[12]  G. Rosen,et al.  Surgical Resection and Intraperitoneal Chemotherapy for Recurrent Abdominal Sarcomas , 1999, Annals of Surgical Oncology.

[13]  M. Leon,et al.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. , 1998, Journal of the American College of Cardiology.

[14]  R. Günther,et al.  Iliac arteries: plain and heparin-coated Dacron-covered stent-grafts compared with noncovered metal stents--an experimental study. , 1997, Radiology.

[15]  B. Dolmatch,et al.  Patency and tissue response related to two types of polytetrafluoroethylene-covered stents in the dog. , 1996, Journal of vascular and interventional radiology : JVIR.

[16]  W. Rostène,et al.  Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit subconjunctival fibroblasts in an ex-vivo model. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[17]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Horwitz Taxol (paclitaxel): mechanisms of action. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  R E Vlietstra,et al.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.

[20]  U. Schuler,et al.  Pharmacokinetics and Metabolism of Mitoxantrone A Review , 1990, Clinical pharmacokinetics.